Billy Wong is a partner based in our Hong Kong office, who concentrates his practice on equity capital markets, debt capital markets, mergers and acquisitions, corporate restructuring, private equity investments, and venture capital financing. Billy assisted numerous companies in Greater China and Southeast Asia in their initial public offerings on stock exchanges in Hong Kong, the US, and Singapore. He regularly advises listed companies on regulatory compliance and corporate governance matters, and a diverse range of corporate transactions, such as debt offerings, follow-on equity offerings, convertible bonds, spin-off listings, dual-listings, cross-border M&A, takeovers, and privatization.
In the last two decades, Billy has worked for companies of all sizes across a spectrum of industries, including pharmaceutical, biotechnology, financial services, telecommunication, energy, technology, retail, education, real estates, food and beverage, and manufacturing. Billy’s practice also extends to handling securities investigations and disciplinary proceedings involving listed companies, as well as advising shareholders of listed companies on their private wealth matters. Billy is a fluent speaker of Mandarin, Cantonese, and English.
A large portion of Billy’s practice involves advising Hong Kong listed companies on public mergers and acquisitions. He also has extensive experience with all kinds of regulatory and corporate governance issues involving Hong Kong listed companies, including investigation matters.
Recommended, Capital Markets: Equity, Hong Kong, The Legal 500 Asia Pacific (2012–2014, 2018–2021)
Recommended, Corporate (including M&A), Hong Kong, The Legal 500 Asia Pacific (2018–2021)
Member, The Law Society of Hong Kong
Member, The Law Society of England and Wales